Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2018 / Cilt: 28 - Sayı: 3

Effect of Resveratrol on Apoptosis and MDM2, RUNX3, RB Gene Expressions in Human Acute Myeloid Leukemia Cells by Transfection of MATRA-Mediated miR-150

MATRA Aracılı miR-150’nin Transfeksiyonu ile İnsan Akut Myeloid Lösemi Hücrelerinde Resveratrol’ün MDM2,RUNX3,RB Gen Ekspresyonları ve Apoptoz Üzerine Etkisi

Pages
147–153
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In HL-60 cells, it was found that miR-150, miR150-Resveratrol combination, resveratrol alone induces apoptosis by 6.48, 6.93 and 4.54 fold, respectively, compared to the control cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic malignancies.
📊
Key Findings & Data:We aimed to evaluate the apoptotic effect of resveratrol (RES), MDM2, RUNX3,RB gene expression exchanges and MicroRNA- 150 (miR-150) transfected with MATRA to HL-60 cells.
💡
Conclusion & Impact:In HL-60 cells, it was found that miR-150, miR150-Resveratrol combination, resveratrol alone induces apoptosis by 6.48, 6.93 and 4.54 fold, respectively, compared to the control cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic malignancies. Magnet assisted transfection (MATRA) is oneof the most effective non-viral transfection methods. We aimed to evaluate the apoptotic effect of resveratrol (RES), MDM2, RUNX3,RB gene expression exchanges and MicroRNA- 150 (miR-150) transfected with MATRA to HL-60 cells. MATRA was used as non-viralvector carrier for miR-150 transfection. IC50 dose of RES was determineted by Fahri et al. Resveratrol and miR-150 transfected cellswere performed apoptosis and MDM2, RUNX3, RB gene expression assays in Human promyelocytic leukemia (HL-60) cells. IC50 doseof RES was used as 5 μM. In HL-60 cells, it was found that miR-150, miR150-Resveratrol combination, resveratrol alone induces apoptosis by 6.48, 6.93 and 4.54 fold, respectively, compared to the control cells. Compared to control cells, MDM2, RUNX3, RB, geneexpressions decreased (miR-150) 1.7, 1.3 and 1.4 fold, (miR-150-resveratrol) MDM2 expression increased 2.73 fold, RUNX3 and RBexpression decreased 6.1, 1.07 fold, respectively. Combination with resveratrol, MDM2, RB decreased 2.9 and 1.4 fold, respectively.Non-viral miR-150 transfection may be effective in leukemia cells, induction of apoptotic effects and gene expression changes, following treatment with resveratrol and miR-150-resveratrol combinations.

Özet

Akut myeloid lösemi (AML), hematopoetik malignitelerin heterojen bir grubudur. “Magnet assisted transfection” (MATRA), non-viral transfeksiyon metodlarında oldukça etkilidir. Çalışmamızda; İnsan promiyelositik lösemi (HL-60) hücrelerine MATRA ile MicroRNA150 (miR-150) transfekte edilip; MDM2,RUNX3,RB gen ekspresyon değişimleri ve resveratrolün apoptotik etkisini değerlendirmeyi amaçladık. MATRA, miR-150 transfeksiyonu için non-viral taşıyıcı olarak kullanılmıştır. Hl-60 hücrelerinde Resveratrolün IC50 dozu, Fahri et al tarafından saptanmıştır. Resveratrol ve miR-150 ile transfekte edilmiş HL-60 hücrelerinde apoptoz ve MDM2, RUNX3, RB gen ekspresyon analizleri yapıldı. HL-60 hücrelerinde Resveratrolün IC50 dozu, 5 µM olarak saptandı. kontrol hücreleriyle karşılaştırıldığında; HL-60 hücrelerinde sırasıyla; miR-150, miR150-Resveratrol kombinasyonu, resveratrolün tek başına apoptozu 6.48, 6.93 ve 4.54 kat indüklediği tespit edilmiştir. Kontrol hücrelerine göre miR-150 tranfeksiyonu yapılanlarda MDM2, RUNX3, RB gen expresyonlarının sırasıyla 1.7, 1.3 ve 1.4 kat azaldığı; miR-150-resveratrol kombinasyonlarında ise MDM2 ekspresyonu 2.73 kat artmış; RUNX3 ve RB ekspresyonları sırasıyla; 6.1, 1.07 kat azalmıştır. Resveratrol ile kombinasyonda MDM2, RB sırasıyla 2.9 ve 1.4 kat azalmıştır. miR-150- resveratrol ve resveratrol kombinasyonları ile tedaviyi takiben gen ekspresyon değişimleri ve apoptotik etkiyi indüklemeleri; non-viral miR-150 transfeksiyonunun lösemi hücrelerinde etkili olabileceğini göstermektedir.

🔖

Cite This Article

KAYABAŞI, Ç., GUNDUZ, C., AVCI, C. B., SAYDAM, G., OKCANOĞLU, T. B., SÜSLÜER, S. Y., YELKEN, B. O. (2022). Effect of Resveratrol on Apoptosis and MDM2, RUNX3, RB Gene Expressions in Human Acute Myeloid Leukemia Cells by Transfection of MATRA-Mediated miR-150. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 28 - Sayı: 3, 147–153. https://ajindex.com/articles/644786

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Smith M, Barnett M, Bassan R, et al. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 50: 197-222, 2004
  2. Daniel MT, Flandrin G, Galton DA, et al. Proposals for the classification of the acute leukaemias. French- American-British (FAB) co- operative group. Br J Hemat 33: 451-458, 1976
  3. Jones ME, Saleem A. Acute promyelocytic leukemia. A re-view of literature. Am J Med 65: 673-677, 1978
  4. Chomienne C, Lanotte M. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature 347: 558-561, 1990
  5. Lee SK, Zhang W, Sanderson BJ. Selective growth inhibition of human leukemia and human lympho blastoid cells by res-veratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem 56: 7572-7577, 2008
  6. Pirola L, Frojdo S. Resveratrol: one molecule, many targets. IUBMB Life 60: 323-332, 2008
  7. Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif 39: 479-93, 2006
  8. Kang JH, Park YH, Choi SW, et al. Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells. Exp Mol Med 35: 467-474, 2003
  9. Cucciolla V, Borriello A, Oliva A, et al. Resveratrol: From basic science to the clinic. Cell Cycle 6: 2495-510, 2007
  10. Georgantas RW 3rd, Hildreth R, Morisot S, et al. CD34+ he-matopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. Proc Natl Acad Sci USA 104: 2750-2755, 2007
  11. Lu J, Guo S, Ebert BL, et al. MicroRNA mediated control of cell fate in megakaryocyte- erythrocyte progenitors. Dev Cell 14: 843-853, 2008
  12. Petriv OI, Kuchenbauer F, Delaney AD, et al. Comprehensive microRNA expression profiling of the hematopoietic hierar-chy. Proc Natl Acad Sci USA 107: 15443-15448, 2010
  13. O’Connell RM, Zhao JL, Rao DS. MicroRNA function in my-eloid biology. Blood 118: 2960-2969, 2011
  14. El Gazzar M, McCall CE. MicroRNAs regulatory networks in myeloid lineage development and differentiation: Regulators of the regulators. Immunol Cell Biol 90: 587-593, 2011
  15. Bissels U, Bosio A, Wagner W. MicroRNAs are shaping the hematopoietic landscape. Haematologica 97: 160-167, 2011
  16. Chen Y, Zhu X, Zhang X, et al. Nanoparticles modified with tumor- targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 18: 1650-1656, 2010
  17. Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leu